Anticorps Monoclonal anti-SCN5A

SCN5A Monoclonal Antibody for Indirect ELISA, IHC, WB

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, Lapin, rat, souris

Applications

Indirect ELISA, IHC, WB

Conjugaison

Non conjugué

CloneNo.

1C2B3

N° de cat : 68273-1-PBS

Synonymes

Nav1.5, HH1, CMPD2, CMD1E, CDCD2



Informations sur le produit

68273-1-PBS cible SCN5A dans les applications de Indirect ELISA, IHC, WB et montre une réactivité avec des échantillons Humain, Lapin, rat, souris

Réactivité Humain, Lapin, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène SCN5A Protéine recombinante Ag19275
Nom complet sodium channel, voltage-gated, type V, alpha subunit
Masse moléculaire calculée 2016 aa, 227 kDa
Poids moléculaire observé227 kDa
Numéro d’acquisition GenBankBC140813
Symbole du gène SCN5A
Identification du gène (NCBI) 6331
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Voltage-gated sodium channels are responsible for initiation and propagation of action potentials in the membranes of neurons and most electrically excitable cells (PMID: 10798388). These channels are composed of a large alpha subunit that forms the ion conduction pore and auxiliary beta subunits (PMID: 11486343). The alpha subunits form a gene family with at least 10 members. Nav1.5, encoded by the SCN5A gene in humans, is a pore forming alpha subunit of voltage-gated sodium channels. Nav1.5 is the principal Na+ channel isoform expressed in cardiomyocytes. Mutations in SCN5A gene have been linked to many cardiac electrical disorders, including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation, and dilated cardiomyopathy (PMID: 23123192).

{{ptg:RelatedPrimaryAntibodies}}